ACO Participants

  • Kyle D. Parish, MD, PSC
  • Dr. Butler & Associates, PLLC
  • James Eickholz
  • Advanced Internal Medicine PLLC
  • Total Life Care, PLLC
  • Four Rivers Internal Medicine PLLC
  • James Kyle Turnbo MD PSC
  • Jeffrey L. Riney M.D. & Associates PLLC
  • James Eickholz
  • Family Practice Care LLC

No participants are involved in a joint venture between ACO professionals and hospitals

ACO Governing Body

  • Turnbo, Kyle, 1, Voting Member, ACO Participant Representative, James Kyle Turnbo MD PSC
  • Eickholz, James, 1, Voting Member, ACO Participant Representative, James Eickholz, M.D., P.S.C
  • Graham, Scott, 1, Voting Member, ACO Participant Representative, Family Practice Care LLC
  • Butler, Danny, 1, Voting Member, ACO Participant Representative, Dr. Butler & Associates, PLLC
  • Lorch, Jason, 1, Voting Member, ACO Participant Representative, Four Rivers Internal Medicine PLLC
  • Frazine, Ryan, 1, Voting Member, ACO Participant Representative, Advanced Internal Medicine PLLC
  • Riney, Jeffrey, 1, Voting Member, ACO Participant Representative, Jeffrey L. Riney MD & Associates PLLC
  • Meeks, Van, 1, Voting Member, ACO Participant Representative, Total Life Care, PLLC
  • Nelson, Jennifer, 1, Voting Member, ACO Participant Representative, Total Life Care, PLLC
  • Jones, Rilla, 1, Voting Member, Medicare Beneficiary Representative, N/A
  • Bartz, Nick, 1, Chair and Voting Member, ACO Executive, Aledade, Inc., N/A

Key Clinical and Administrative Leadership

  • Executive Director: Mr. Nick Bartz
  • Medical Director: Dr. Ryan Frazine
  • Compliance Officer: Mr. Brian Lynch
  • Quality Assurance/Improvement Officer: Dr. Emily Maxson

ACO Committees and Committee Leaderships

  • Beneficiary Engagement Committee: name
  • Compliance Committee: Mr. Brian Lynch
  • Evidence-Based Medicine Committee: name
  • Performance Improvement Committee: name
  • Transitions of Care Committee: name

Composition of ACO

  • Networks of individual practices of ACO professionals

Amount of Shared Savings/Losses

  • First Agreement Period
  • Performance Year 2016, $1,110,552

How Shared Savings Are Distributed

First Agreement Period

Performance Year 2016

10%

Reinvest in infrastructure

30%

Invested in redesigned care processes/resources

60%

Distribution to ACO Participants

100%

Primary Care Professionals

N/A

Specialists

N/A

Hospital

Payment Rule Waivers

  • No, our ACO does not utilize the SNF 3-Day Rule Waiver

Quality Reporting

2016 Quality Performance Results:

ACO#Measure NameRateACO Mean
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.
ACO-1CAHPS: Getting Timely Care, Appointments, and Information 82.5980.51
ACO-2CAHPS: How Well Your Providers Communicate 96.0993.01
ACO-3CAHPS: Patients’ Rating of Provider 95.2592.25
ACO-4CAHPS: Access to Specialists 84.2783.49
ACO-5CAHPS: Health Promotion and Education59.8960.32
ACO-6CAHPS: Shared Decision Making 74.7875.4
ACO-7CAHPS: Health Status/Functional Status 71.772.3
ACO-34CAHPS: Stewardship of Patient Resources 34.4326.97
ACO-8Risk Standardized, All Condition Readmission14.2714.7
ACO-35Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)18.8118.17
ACO-36All-Cause Unplanned Admissions for Patients with Diabetes56.8153.2
ACO-37All-Cause Unplanned Admissions for Patients with Heart Failure79.6375.23
ACO-38All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions60.4559.81
ACO-9Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)7.249.27
ACO-10Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)21.7214.53
ACO-11Percent of PCPs who Successfully Meet Meaningful Use Requirements94.1282.72
ACO-39Documentation of Current Medications in the Medical Record10087.54
ACO-13Falls: Screening for Future Fall Risk 44.6464.04
ACO-14Preventive Care and Screening: Influenza Immunization78.2568.32
ACO-15Pneumonia Vaccination Status for Older Adults7569.21
ACO-16Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up69.9274.45
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention51.9590.98
ACO-18Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan37.8453.63
ACO-19Colorectal Cancer Screening79.1561.52
ACO-20Breast Cancer Screening81.3367.61
ACO-21Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 51.8176.79
ACO-42Statin therapy for the Prevention and Treatment of Cardiovascular Disease80.5377.72
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control 46.8718.24
ACO-41Diabetes: Eye Exam22.9644.94
ACO-28Hypertension (HTN): Controlling High Blood Pressure 61.370.69
ACO-30Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic72.3985.05
ACO-31Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)66.6788.67
ACO-33Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)66.3979.67

For 2016 Quality Performance Results please visit: https://data.cms.gov/Special-Programs-Initiatives-Medicare-Shared-Savin/2016-Shared-Savings-Program-SSP-Accountable-Care-O/3jk5-q6dr/data

Note: In the Quality Performance Results file(s) above, search for “AmpliPHY of Kentucky ACO LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A84924 in the public use files on data.cms.gov.